Have your own idea? Try our Stock Screener
Last week, the Biotech industry hasn't moved much but Vertex Pharmaceuticals is up 3.0% in that time. As for the the longer term, the industry is up 14% over the past 12 months. Looking forward, earnings are forecast to grow by 30% annually.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 01 Sep 2024 | US$909.4b | US$113.1b | -US$35,712,101,098.38 | 24x | -25.5x | 8x |
Tue, 30 Jul 2024 | US$1.2t | US$164.9b | -US$28,963,503,229.83 | 26.8x | -43x | 7.5x |
Thu, 27 Jun 2024 | US$1.2t | US$164.4b | -US$27,986,453,486.34 | 27.7x | -41.4x | 7x |
Sat, 25 May 2024 | US$1.1t | US$164.6b | -US$26,747,196,206.43 | 23.8x | -42.1x | 6.8x |
Mon, 22 Apr 2024 | US$1.1t | US$164.2b | -US$23,311,155,066.52 | 20.4x | -45.9x | 6.5x |
Wed, 20 Mar 2024 | US$1.2t | US$167.4b | -US$21,814,367,317.91 | 13.8x | -53.5x | 7x |
Fri, 16 Feb 2024 | US$1.2t | US$169.1b | -US$20,723,712,339.70 | 18.7x | -55.6x | 6.8x |
Sun, 14 Jan 2024 | US$1.4t | US$204.8b | -US$22,497,556,941.00 | 18.8x | -63.9x | 7x |
Tue, 12 Dec 2023 | US$1.3t | US$204.6b | -US$22,091,146,901.00 | 18.7x | -58.6x | 6.3x |
Thu, 09 Nov 2023 | US$1.2t | US$204.1b | -US$20,943,935,957.00 | 16.6x | -59.3x | 6.1x |
Sat, 07 Oct 2023 | US$1.3t | US$207.4b | -US$13,060,168,797.00 | 17.2x | -96.3x | 6.1x |
Mon, 04 Sep 2023 | US$1.3t | US$207.6b | -US$12,421,503,459.00 | 18.4x | -104.2x | 6.2x |
Wed, 02 Aug 2023 | US$1.1t | US$186.2b | -US$14,964,083,330.00 | 14.7x | -76.4x | 6.1x |
Fri, 30 Jun 2023 | US$1.1t | US$186.2b | -US$16,044,205,476.00 | 13.6x | -69.4x | 6x |
Sun, 28 May 2023 | US$1.1t | US$185.9b | -US$16,045,698,796.00 | 11.2x | -69.9x | 6x |
Tue, 25 Apr 2023 | US$1.2t | US$198.6b | -US$3,172,070,914.00 | 13.7x | -374.7x | 6x |
Thu, 23 Mar 2023 | US$1.1t | US$199.5b | -US$3,522,273,239.00 | 12.4x | -313.9x | 5.5x |
Sat, 18 Feb 2023 | US$1.2t | US$202.6b | -US$64,851,937.00 | 16.5x | -17785.7x | 5.7x |
Mon, 16 Jan 2023 | US$1.2t | US$203.7b | US$1.8b | 14.5x | 670.9x | 5.8x |
Wed, 14 Dec 2022 | US$1.2t | US$202.9b | US$1.5b | 14.8x | 792.8x | 5.8x |
Fri, 11 Nov 2022 | US$1.1t | US$201.7b | US$975.9m | 14.1x | 1133.1x | 5.5x |
Sun, 09 Oct 2022 | US$1.0t | US$206.1b | US$5.4b | 14.9x | 190.3x | 5x |
Tue, 06 Sep 2022 | US$1.0t | US$206.1b | US$6.1b | 14.6x | 171.4x | 5x |
Thu, 04 Aug 2022 | US$1.1t | US$212.1b | US$10.6b | 16x | 102.1x | 5.1x |
Sat, 02 Jul 2022 | US$1.1t | US$212.1b | US$11.0b | 15.8x | 95.5x | 5x |
Mon, 30 May 2022 | US$1.0t | US$212.7b | US$11.2b | 15.5x | 91.6x | 4.8x |
Wed, 27 Apr 2022 | US$1.2t | US$226.3b | US$14.6b | 16.9x | 81x | 5.2x |
Fri, 25 Mar 2022 | US$1.3t | US$221.9b | US$11.2b | 18.9x | 115x | 5.8x |
Sun, 20 Feb 2022 | US$1.2t | US$216.5b | US$5.7b | 21.8x | 213.9x | 5.6x |
Tue, 18 Jan 2022 | US$1.3t | US$212.1b | US$2.5b | 24.4x | 529.2x | 6.2x |
Thu, 16 Dec 2021 | US$1.4t | US$211.9b | US$3.1b | 25.9x | 460.4x | 6.8x |
Sat, 13 Nov 2021 | US$1.5t | US$212.2b | US$4.0b | 27.1x | 365.8x | 6.9x |
Mon, 11 Oct 2021 | US$1.5t | US$196.3b | -US$2,597,765,814.00 | 23.3x | -560.6x | 7.4x |
Wed, 08 Sep 2021 | US$1.6t | US$196.4b | -US$2,275,254,373.56 | 21.8x | -696.8x | 8.1x |
-696.8x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 0.066% | |
Healthcare | 0.91% | |
Biotech | 0.13% | |
Biotech | 0.13% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
VRTX Vertex Pharmaceuticals | US$495.89 | 3.0% +US$3.8b | 41.2% | PS12.4x | |
GILD Gilead Sciences | US$79.00 | 3.0% +US$2.8b | 3.1% | PE93.3x | |
AMGN Amgen | US$333.83 | 1.5% +US$2.7b | 30.0% | PE57.3x | |
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
GRPH Graphite Bio | US$22.26 | 539.7% +US$1.1b | 861.6% | PB7.1x |